KYORIN Pharmaceutical (4569) · InitiativeRestated
Extension and Automatic Renewal of the Uritos Distribution Agreement
First written in FY2017-Q2. 3 of 4 entries say "Restated". Latest entry: FY2019.
4entries
4years
0from disclosures
How it moved
Same theme, other companies
Extension and Automatic Renewal of the Uritos Distribution AgreementA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2019RestatedAnnual report
「Uritos | Eisai Co., Ltd. | 2009 | Through 31 January 2022 (automatically renewable)」
The company continues to disclose the contract term through 31 January 2022 and the automatic renewal conditions for the Uritos sales agreement. - FY2018RestatedAnnual report
「Uritos | Eisai Co., Ltd. | 2009 | Through 31 January 2022 (automatically renewable)」
The company continues to disclose the term through 31 January 2022 and the automatic renewal conditions for the Uritos sales agreement. - FY2017RestatedAnnual report
「Uritos | Eisai Co., Ltd. | 2009 | Through 31 January 2022 (automatically renewable)」
The company continues to disclose the term through 31 January 2022 and the automatic renewal conditions for the Uritos sales agreement. - FY2017-Q2First statedAnnual report
「The contract term was changed from “15 years from the date of execution” to “through 31 January 2022 (automatically renewable).”」
The distribution agreement for Uritos with Eisai was changed to run through 31 January 2022, with automatic renewal.